companydata.dkcompanydata.dk

TJ Biotech Holding ApS: Financial statements 2024

CVR: 41953616

Source: annual report 2024, Danish Business Authority

01/01/2024 – 31/12/2024

TJ Biotech Holding ApS (CVR 41953616) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK 118,224 and a net result of DKK 667,738 compared with DKK -9,513,527 the year before. That is an increase of 68.9% compared with the year before. Equity in the 2024 report amounted to DKK 14,422,569. The solvency ratio was 76.1%.

Gross Profit
DKK 118,224
Profit/Loss
DKK 667,738
Equity
DKK 14,422,569
Total Assets
DKK 18,946,851
Employees
0

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2024-118K668K14.4M0
2023-70K-9.5M13.8M0
2022-54K-216K23.3M0
2021-1.7M413K23.5M1
2020-1.4M90K23.1M1

Official annual report

View the official annual report directly on the page with a Pro subscription.

Screen every Danish company

Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.

Try company screening

Events in 2024

TJ Biotech Holding ApS: The 2023 annual report is outJul 5, 2024

TJ Biotech Holding ApS has published its annual report for 2023. Gross profit came to DKK 70,004, and the net result was DKK -9,513,527.

About TJ Biotech Holding ApS

TJ Biotech Holding ApS is a Danish company of the type Anpartsselskab based in Holte, founded in 2020. The company is registered under the industry Virksomhedsrådgivning og anden ledelsesrådgivning. The management consists of Thomas Engelbrecht Nordkild Jonassen. The company is owned by Thomas Engelbrecht Nordkild Jonassen. The company has 1 employee (2021). In 2025, the company reported a gross profit of DKK 70,424 and a net result of DKK 4,184,576 compared with DKK 667,738 the year before. Equity in the 2025 report amounted to DKK 18,607,145.

Source: annual report 2025, Danish Business Authority

Other financial years